Seetharam, Shakuntla, Kalathur S. Ramanujam, and Bellur Seetharam. Intrinsic factor receptor activity and cobalamin transport in bile duct-ligated rats. Am. J. PhysioZ. 262 (Gastrointest.
Liver Physiol. 25): G210-G215, 1992.-The intrinsic factor (IF)-cobalamin (Cbl) receptor activity in the mucosal homogenates progressively decreased after bile duct. ligation in the rat, and 80% of the receptor activity was decreased in 96 h after ligation. The activity was restored to normal values of 5.5-6 pmol of IF-["'Co]Cbl bound/g mucosa when the assays were performed with both conjugated and unconjugated bile acids. When ["'Co]Cbl bound to intrinsic factor was orally administered, the tissue levels of ["7Co]Cbl were decreased by 75-80% in bile duct-ligated rats. The apical membrane receptor activity was also decreased after bile duct ligation; however, the activity was stimulated twofold by the addition of ileal cytosol and threefold with the addition of both ileal cytosol and taurocholate
(1 mM). Enhanced binding of IF- ["'Co] Cbl to the apical ileal brush-border membrane occurred with the use of dialyzed ileal cytosol but not with cytosol isolated from duodenal or proximal jejunal mucosa. The enhanced binding obtained with ileal cytosol was abolished after its treatment with trypsin. These results suggest that luminal bile acids optimize the binding of IF-Cbl by the ileal membrane receptor via interactions with a cytosolic factor and thus influence the gastrointestinal absorption of cobalamin.
absorption; cytosolic factor; brush-border membrane THERE IS EVIDENCE based on studies using patients with obstructive jaundice and T-tube drainage (34) and bile fistula rats (4) that luminal bile is important in the intrinsic factor (IF) -mediated ileal absorption of cobalamin (Cbl). However, the exact step at which bile or bile acids regulate Cbl absorption is not known. The initial event in the gastrointestinal absorption of Cbl is the complexing of dietary Cbl by IF in the intestinal lumen (25) . Previous in vitro studies (32, 33) have reported that bile and bile acids inhibit Cbl binding by IF. However, the inhibition noted has been shown to be due to the displacement of Cbl from IF by haptocorrin (R-type Cbl binder), which is present in both human bile and commercially available bile acids (28). the amount bound in the presence of EDTA from the amount bound in the presence of CaC12. In some assays, the apical membranes were washed with EDTA at pH 5 to remove endogenous IF-Cbl, because the binding of IF-Cbl occurs optimally at pH 7.4 and requires Ca"'.
Male adult rats (150-175 g) were used for bile duct ligation. The common bile duct was ligated under anesthesia essentially according to Kaplan and Righetti (14) . Briefly, adult male rats were lightly anesthetized, subjected to a midline incision, and the common bile duct was isolated and tied off as close to the liver as possible to minimize damage to the pancreatic ducts. After surgery, the animals were given free access to food and water. The animals were alert and feeding normally 12-24 h after the operation . To ascertain the absence of any damage to the pancreatic secretions, the total proteolytic activity in the luminal washings (0.9% NaCl) was determined by assessing the hydrolysis of casein at pH 7.4 as described earlier (17). Some rats were sham operated with laparotomy and the internal manipulation that were required with the BDL rats. At various times after bile duct ligation in some rats, the entire length of the intestine was removed and the lumen was washed with icecold saline. Mucosa was scraped with a glass slide from duodenum, proximal jejunum, distal jejunum, and ileum. The mucosa was homogenized using (in mM) 50 mannitol, 2 HCl buffer at pH 7.4 containing 140 NaCl, 0.1 phenylmethylsulfonyl fluoride (PMSF), and 2 benzamidine, as well as 0.3 aprotonin (buffer A ). Apical brush-border and internal membranes from control and BDL rats (96 h) were isolated by the Ca'+-aggregation method of Schmitz et al. (24) as modified by Kessler et al. (15) and suspended in buffer A. This method has been validated in the rat intestine (7) to quickly separate the apical and internal membranes by differential centrifugation of the CaCl,-treated homogenates.
The Ca"+ precipitate obtained at low-speed centrifugation contained the intracellular membranes, predominantly endoplasmic reticulum and/or Golgi. The apical membranes were enriched for alkaline phosphatase, a brush-border marker by 20-to 25-fold with a recovery between 25 and 30%. The cytosolic fraction from different anatomic regions of the intestine from BDL (96 h) or control rats was prepared by centrifuging a 10% (wt/vol) homogenate prepared in sucrose (0.25 M) and EDTA (1 mM) for 1 h at 105,000 g. The clear supernatant below the top fluffy lipid layer was carefully removed.
The IF-["'Co] Cbl-binding activity in the mucosal homogenates or isolated apical membranes was determined as follows. An aliquot of mucosal homogenate (l-l.2 mg protein) was first preincubated with bile acids (1 mM) for 30 min at 22°C before the addition of rat IF-["'Co]Cbl (2 pmol). The effect of cytosol (500-600 pug protein) on the binding of IF-["Co]Cbl (2 pmol) to the apical brush-border membrane (500-600 pg protein) was carried out first by a preincubation of the apical membranes with the cytosol in the presence or absence of taurocholate (1 mM) for 30 min at 22°C. The binding reaction was initiated with the addition of rat IF-["'Co]Cbl (2 pmol) and allowed to incubate for an additional 60 min at 22°C. For some experiments, the dialyzed cytosol used was obtained after dialysis of cytosol (20 ml) against 12 liters of 10 mM Tris-WC1 buffer pH 7.4 for 24 h with a 6-liter change after 12 h. For some assays, the cytosol treated with tosyl-phenylalanine chloromethyl ketone (TPCK)-trypsin
(1 mg cytosol protein with 0.1 mg TPCKtrypsin) for 4 h at 37°C was used. The trypsin digestion of the cytosol was terminated by addition of a mixture of protease inhibitors.
The final concentration of these inhibitors was 0.1 mM for PMSF and 1 mM for benzamidine.
The transport of ["Co]Cbl to the tissues in control and BDL (96 h) rats was carried out as described earlier (21). Briefly IF-['Co]Cbl (3.7 pmol) was directly instilled in the stomach of rats through a feeding tube. After 1 or 4 h following the instillation of the label, the animals were killed. The intestine was carefully removed from the pylorus to the ileocecal end, cut into 10 equal segments, and counted for ["Co]Cbl. The liver and kidneys were removed, rinsed with ice-cold saline, blotted dry, weighed, cut into small pieces, and counted for ["Co]Cbl using Beckman gamma 4,000 counter. Alkaline phosphatase in the mucosal homogentes and the isolated apical brush-border membrane was assayed using p-nitrophenylphosphate (PNPP) as a substrate (11) (expressed as pmol of PNPP hydrolyzed l min-' . mg protein-').
The protein concentrations in the various fractions were determined according to Lowry et al. (18) using bovine serum albumin as standard.
RESULTS
Effect of bile duct ligation on luminal protease and mucosal receptor actiuity. The luminal proteolytic activity was measured in the washings from the sham-operated and the BDL rats to confirm that the ligation had not affected pancreatic secretions into the lumen. Total proteolytic activity expressed as trypsin varied from animal to animal but was 75-95 pg/ml in sham-operated rats and 65-110 pg/ml in rats 4 days after BDL. In the BDL rats, the mucosal receptor activity sharply declined to 50% of the control value in -24 h, and further decline (75-80%) of the activity occurred slowly for up to 96 h (Fig. 1) . In contrast, the alkaline phosphatase activity rose by 100% in 12 h and declined to 50% of the control values 96 h after the ligation (Fig. 1) . Because the maximum loss of the receptor activity occurred between 72 and 96 h after bile duct ligation, all subsequent studies were performed using rats whose bile duct was ligated 96 h before the experiments.
Effect (Fig. 2, top ) or 4 h (Fig. 2, bottom) The recovery of receptor activity expressed as a percent of total homogenate receptor activity in the internal membrane (Table  2, parentheses) was the same (~60%) for both control and BDL rats. However, the recovery of the receptor activity in the apical membranes from BDL rats was only 8%, whereas in the membranes from sham-operated rats it was 15-M%. When the apical membranes were Cbl to mucosal homogenates and isolated apical brush border from BDL rats. The addition of bile acids to the assay system increased the binding of IF-["7Co]Cbl to the mucosal homogenates from 0.8 to 3-6 pmol/g mucosa (Table 3) . All the bile acids tested were equally effective. The activity restored with taurochenodeoxycholate was very close to the activity of 6 pmol/g noted in the absence and between 6 and 7 pmol/g noted in the presence of bile salts noted using homogenates from the sham-operated animals (data not shown). None of the bile acids tested had any effect on the binding of IF- ['7Co ]Cbl by the brush borders. These results indicated that the bile saltmediated binding of IF- ["7Co ]Cbl binding to the homogenates from BDL rats may be mediated by a cytosolic factor that is present during the assay for the receptor using the mucosal homogenates but not using the apical membranes. This hypothesis was tested directly by a series of in vitro reconstitution experiments using cytosol fraction isolated from homogenates prepared using mucosa from various regions of the gut. to the ileal brush-border membrane isolated from BDL rats was not affected by the addition of taurocholate (Fig. 3) . When the ileal cytosolic protein in the ratio (1:l) of membrane protein was added, taurocholate increased the binding by nearly threefold when the source of the CYtosol was either distal jejunum or ileum. Taurocholatemediated binding of IF-["'Co] Cbl (180 fmol/mg protein) was very close to control values (150 fmol/mg protein) with the cytosol fraction obtained from ileum but not from either duodenum or proximal jejunum. The cytosol from distal jejunum was moderately effective in the presence of taurocholate. When the ileal cytosol was dialyzed, its ability to enhance the binding of IF-["7Co]Cbl was unaffected. However, trypsin treatment abolished the activation of IF-["7Co]Cbl binding whether taurocholate was present or not (Fig. 3) . Rat ileal cytosol used for reconstitutio n with the apical membranes had intrinsic ['7Co]Cbl-binding activity of only 40-50 fmol/ml, an amount too small to contribute to the enhanced binding noted with taurocholate and this fraction. The replacement of taurocholate with other detergents such as Triton X-100 (0.2-l%), NP-40 (l%), and sodium dodecyl sulfate (0.5%) was not effective (data not shown). Ileal cytosol from BDL rats was equally effective as ileal cytosol from sham-operated animals in restoring the receptor activity. (Fig. 3) .
DISCUSSION
The gastrointestinal absorption and transport of dietary and biliary Cbl are extremely complex events in- volving several binding and transfer reactions in the lumen of the gut, on the surface membrane, and within the absorptive enterocytes (25). The luminal factors that influence the absorption of Cbl include the pancreatic proteases (1, 2) and bile (34). Although the mechanism by which the pancreatic proteases mediate Cbl absorption is known (1, 19), the exact step at which bile or components of bile regulate Cbl absorption is not clear. Studies by Bergesen et al. (3, 5) have shown that Cbl malabsorption in rats with bile fistula is not due to bacterial overgrowth or to impairment of epithelial function or mucosal hypoplasia. One study (12) has indicated that bile acids may act as a "releasing factor" to release Cbl from IF. However, it is important to note that IFCbl is internalized via its receptor (13, (20) (21) (22) 30 ) and the release of Cbl occurs within the enterocyte. Moreover, the release of Cbl from IF in vitro by bile or bile acids is due to the presence of haptocorrin (R-type Cbl binder), which is present in both bile and commercially available bile acids (28). Thus it is highly unlikely that bile acids have a role in the intraluminal or intracellular release of Cbl from IF. Earlier studies (9, 12, 28) have suggested that bile acids may have a role in modulating IF-Cbl binding by the receptor, an important step before the entry of IF-Cbl into the cell and the exit of Cbl from the enterocytes. The mechanism by which the binding is affected is not known. The current studies have addressed this issue using rats whose bile ducts were ligated. In this model, the pancreatic function was not affected, because the secretion of proteolytic activity into the lumen of the gut was not decreased. In the current study, we chose to use bile-obstructed rats rather than bile fistula rats. One disadvantage with this model is that, although bile acid levels are decreased on the luminal side of the enterocytes and in the mucosa, their levels in other tissues are increased. Despite this shortcoming, the bile-obstructed rats have been extensively used to study the effect of bile on intestinal mucosal enzyme activity levels (8, 16, 31) .
The data presented here demonstrate that the absence of luminal bile resulted in decreased binding of IF-["'Co] -Cbl to the surface membrane receptor (Table 1 ) and the noted Cbl transport to the tissues (Table 2 ) may be related to this inhibition. The bile acids in the presence of a ileal cytosolic factor may unmask the ligand (IFCbl) binding sites of membrane-bound receptor. Several lines of evidence support such a conclusion. First, BDL caused a progressive loss of the receptor activity in the mucosal homogenates (Fig. 1) and in the apical membranes ( Table 2 ). The washing of the apical membranes with EDTA at pH 5 did not enhance the binding of IF-["7Co]Cbl, suggesting that the unmasking of binding sites is not due to the removal of endogeneous IF-Cbl bound in increased amounts to the surface receptor. The recovery of the receptor in the internal membranes from both control and BDL rats was the same suggesting that absence of bile acids did not result in decreased amount of receptor delivered to the apical membrane and hence in the accumulation of intracellular receptor (Table 2) (Fig. 3) . This value is close to the value of 150 fmol of IF-[57Co]Cbl bound/mg protein using the apical membranes from sham-operated rats.
Although the nature of cytosolic factor that optimizes IF-[57Co]Cbl binding to the apical membranes isolated from BDL rats is not known, it is nondialyzable, trypsin sensitive, and its expression is regulated along the horizontal axis of the gut (Fig. 3) . Another cytosolic protein whose expression has recently been shown to be limited in the ileum is the lipid/bile acid binder (23). It is interesting to speculate whether functional topography of the IF-Cbl receptor is influenced by the binding of bile acids to its carrier proteins. The cytoslic fraction used in this study bound very small amounts [57Co]Cbl (40-50 fmol/ml), an amount not sufficient to contribute to the noted effect of cytosol in enhancing the binding of exogenously added IF-[57Co]Cbl. Thus the observed increase in the binding of Cbl by the membrane receptor in the presence of ileal cytosol is not an artifact of the assay. Moreover, in the assay system all the ["'Co]-Cbl was bound to IF and the amount (2 pmol) of IF-[57Co]Cbl was enough to saturate the receptor (data not shown). Although the ileal cytosol by itself enhanced the binding of IF-[:"Co]Cbl by nearly twofold, the addition of taurocholate had an additional effect. Thus it seems that both the bile salts and the cytosolic factor are needed for the optimal binding of IF-[57Co]Cbl by the membrane receptor. How this is accomplished in vivo is not known. This study is another example of the effect of bile acids in modulating the activity of intestinal membrane proteins. Bile acids have been shown to affect the activity of several intestinal apical membrane enzymes (8, 16, 31) . In some instances, such as y-glutamyltranspeptidase, the bile acids modulate the activity by directly acting on the enzyme molecule (10). We have shown previously (28) that bile acids enhanced the binding of IF- ["'Co] Cbl to the canine ileal membrane but not to the pure receptor. Thus the role of bile acids on the receptor activity is a membrane event and could have implications in the normal absorption of Cbl.
In conclusion, the results of the present study show that in the absence of luminal bile orally adminstered IF-["'Co] Cbl accumulates in the intestinal lumen because of decreased binding to the surface receptor resulting in decreased transport of [57Co]Cbl to the tissues. Although these studies suggest a role for the luminal bile in optimizing IF-Cbl and its receptor interactions, further studies are needed to define the role of cytosolic protein and bile acids in such an interaction.
